Thyroid medications recalled across US, at least 4 people reported problems


WASHINGTON (NewsNation Now) — Two types of thyroid medications are being voluntarily recalled by the manufacturer, according to the Food and Drug Administration. The NP Thyroid tablets made by Acella Pharmaceuticals, LLC have possibly led to at least four reports of adverse effects.

According to the company statement, several problems, including heart issues, could be associated with the recalled drugs.

Patients being treated for hypothyroidism (underactive thyroid), who receive sub potent NP Thyroid®, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight. There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development. In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia.

Acella Pharmaceuticals, LLC in fda statement

NP Thyroid 15 and NP Thyroid120 are being recalled because testing found the lots to be sub-potent.

“The product may have as low as 87% of the labeled amount of levothyroxine,” according to the FDA announcement.

The prescription drugs were sent to pharmacies across the country.

“Patients who are currently taking NP Thyroid® from the lots being recalled should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription,” according to the FDA announcement.

ProductNDCLot #Exp. Date
NP Thyroid® 15, Thyroid Tablets, USP, ¼ grain (15 mg)42192-327-01M327E19-1October 2020
NP Thyroid® 120, Thyroid Tablets, USP, 2 grain (120 mg)42192-328-01M328F19-3November 2020
15 mg tablet picture
Recalled Product Photo via FDA
120 mg tablet picture
Recalled Product Photo via FDA
NPThyroid15, Thyroid Tablets, USP, ¼ grain (15 mg), 100 tablets, front label
Recalled Product Photo via FDA
NPThyroid120, Thyroid Tablets, USP, 2 grain (120 mg), 100 tablets, front label
Recalled Product Photo via FDA

Patients are encouraged to contact the company with questions and report adverse effects to the FDA.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest BRProud Articles

More Local News

Stay up to date with the latest news by downloading the BRProud App from the App Store or Google Play.

Sponsored By

Heartbeat Segment logo

Cardiovascular Institute of the South was founded in 1983 by Dr. Craig Walker, who first established the company as a one-physician practice in Houma, Louisiana. Driven by a desire to serve and heal people in his community, Dr. Walker envisioned CIS as a leader in the development of new techniques and technologies in the treatment of both coronary and peripheral artery diseases.

Today, CIS continues to grow and expand to multiple locations striving to make the most advanced cardiovascular care accessible to a wide spectrum of communities across Louisiana, Texas, and Mississippi. We believe that our unwavering dedication to the CIS mission of providing the highest quality cardiovascular care has truly been the cornerstone of this successful growth.

Request an Appointment

Tune in to Heartbeat on for the latest news in heart health and tips on how you can keep your blood pressure in check.


Trending Stories